Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q2 2026 Earnings

May 5Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.75

-0.54

-0.34

-0.13

Details

Expected EPS

-0.56804283909

Actual EPS

-0.6315086

Surprise EPS

-0.06

Surprise Percent

-11.17%

Description

⁨Spyre Therapeutics⁩ (⁦3920.F⁩) has reported earnings of ⁦-0.6315086⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.